patented technology based on peptides (small proteins) that efficiently cross biological barriers, such as the blood-brain barrier that protects the brain
Gate2Brain has raised €9.5M across 2 funding rounds from 1 investor, most recently a round in Jun 2026. Based in Barcelona, Spain; active in Healthtech. Data as of 7 Aug 2026.
Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2026-06-18 | Other | €7.0M | — | View deal → |
| 2022-12-21 | Other | €2.5M | EIC Accelerator | View deal → |
